Pathway Therapeutics pathwaytx.com

Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases. The company's lead product, PWT33597, is a balanced, dual PI3K alpha/mTOR inhibitor and the first compound with this profile to enter the clinic. Dual inhibition of PI3K and mTOR shuts down the PI3K/mTOR pathway more effectively than single target inhibitors. Of the four PI3K isoforms, PI3K...Show all

Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases. The company's lead product, PWT33597, is ...Show all

Company (Alive / Active)

All investors data 5 Investors

• Breast Cancer Research Trust
• CM Capital
• GBS Venture Partners
• New Zealand Venture Investment Fund
• Trans Tasman Commercialisation Fund

There is no Investors data available for this company. Please select another tab.

There is no Board of Directors data available for this company. Please select another tab.

Board Members

There is no Competitors data available for this company. Please select another tab.

Competitors

See all 0 competitors

Patents